Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Cochrane on Surgical Approaches for Prostatectomy

Cochrane; 2017 Sep 12; Ilic, Evans, Allan, et al

Publish date:

Patients receiving laparoscopic radical prostatectomy (LRP) or robotic-assisted radical prostatectomy (RARP) experience less near-term postoperative pain and shorter hospitalizations than those undergoing open radical prostatectomy (ORP), according to a Cochrane review of 2 randomized controlled trials involving 446 men. There appear to be no other differences, however. Among the findings:

  • No differences in prostate cancer-related mortality, recurrence, or overall death rates were seen.
  • Men’s quality of life relative to urinary and sexual function was comparable.
  • Postoperative surgical complications also appeared to be similar.
  • Pain 1 to 7 days after surgery appeared to be lessened with LRP or RARP, but no difference in this regard was seen at 12 weeks.
  • Men who had LRP or RARP were more likely to have shorter hospital stays and require fewer blood transfusions.

Citation:

Ilic D, Evans S, Allan C, Jung J, Murphy D, Frydenberg M. Laparoscopic and robotic-assisted versus open radical prostatectomy for the treatment of localised prostate cancer. Cochrane Database of Systematic Reviews. 2017, Issue 9. Art. No.: CD009625. doi:10.1002/14651858.CD009625.pub2.

This Week's Must Reads

Must Reads in Genitourinary Cancer

Cochrane On Bisphosphonates for Prostate Cancer, Cochrane; 2017 Dec 26; Macherey, Monsef, et al

Cochrane on Reconstructing the Pancreatic Stump, Cochrane; 2017 Sep 12; Cheng, Briarava, et al

Cochrane on EDMA for Bladder Cancer Treatment, Cochrane; 2017 Sep 12; Jung, Gudeloglu, et al

Cochrane on Surgical Approaches for Prostatectomy , Cochrane; 2017 Sep 12; Ilic, Evans, Allan, et al

FDA Approves First Biosimilar to Treat Cancer, FDA news release; 2017 Sep 14